Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
World Neurosurg ; 185: e860-e866, 2024 05.
Artigo em Inglês | MEDLINE | ID: mdl-38447741

RESUMO

BACKGROUND: Patients with acute vertebral compression fractures (aVCFs) are frequently transferred to an emergency department by ambulance. The most useful imaging modality is magnetic resonance imaging (MRI); however, which patients should be prioritized for MRI evaluation may be unclear. The aim of this study was to evaluate plasma D-dimer levels as a biomarker for aVCFs. METHODS: This retrospective cohort study included patients with low back pain in the emergency department between November 2017 and October 2020. Patients with infections, patients with coagulation disorders, and patients without D-dimer level measurements were excluded. The presence of an aVCF was detected with MRI. Blood samples were collected for routine blood tests. The predictive factors for aVCFs were evaluated with univariate and multivariable logistic regression analyses. RESULTS: Overall, 191 consecutive MRI evaluations were ordered. After exclusions, 101 patients were reviewed. Based on MRI, 65 (64.4%) patients were diagnosed with aVCF. The presence of aVCF was significantly correlated with age (odds ratio [OR] = 1.052, 95% confidence interval [CI] 1.018-1.191), an old vertebral compression fracture (OR = 3.290, 95% CI 1.342-8.075), hemoglobin (OR = 0.699, 95% CI 0.535-0.912), and D-dimer levels (OR = 1.829, 95% CI 1.260-2.656). Results from a multivariable logistic regression analysis showed that D-dimer levels (OR = 1.642, 95% CI 1.188-2.228) remained a significant risk factor for the presence of aVCFs after adjustment for potential confounders. CONCLUSIONS: Plasma D-dimer levels can provide useful diagnostic information about whether an aVCF is present.


Assuntos
Biomarcadores , Serviço Hospitalar de Emergência , Produtos de Degradação da Fibrina e do Fibrinogênio , Fraturas por Compressão , Dor Lombar , Imageamento por Ressonância Magnética , Fraturas da Coluna Vertebral , Humanos , Produtos de Degradação da Fibrina e do Fibrinogênio/análise , Feminino , Masculino , Fraturas por Compressão/sangue , Fraturas por Compressão/diagnóstico por imagem , Fraturas por Compressão/complicações , Estudos Retrospectivos , Pessoa de Meia-Idade , Idoso , Fraturas da Coluna Vertebral/sangue , Fraturas da Coluna Vertebral/diagnóstico por imagem , Dor Lombar/sangue , Dor Lombar/etiologia , Dor Lombar/diagnóstico , Biomarcadores/sangue , Idoso de 80 Anos ou mais , Estudos de Coortes , Adulto
2.
J Neurosurg Case Lessons ; 1(15): CASE20175, 2021 Apr 12.
Artigo em Inglês | MEDLINE | ID: mdl-36046799

RESUMO

BACKGROUND: Intravenous tissue plasminogen activator (IV t-PA) is effective for the treatment of distal artery occlusion. However, after the use of IV t-PA, vascular occlusion in unaffected territories may occur. Early recurrent ischemic stroke (ERIS) is defined as the occurrence of new neurological symptoms that suggest the involvement of initially unaffected vascular territories after intravenous thrombolysis (IVT). The authors reviewed the cases of ERIS that occurred within 24 hours after treatment with IVT. OBSERVATIONS: A 75-year-old woman with occlusion in the M2 segment of the left middle cerebral artery (MCA) was treated with IV t-PA. However, 360 minutes later, the patient presented with occlusion in the M1 distal segment of the contralateral side, the right MCA, which was recanalized by endovascular treatment. Her modified Rankin Scale score was 4; however, aphasia was not observed. She was transferred to a rehabilitation hospital after 3 months. LESSONS: ERIS is an extremely rare but catastrophic event. The underlying mechanism of ERIS most likely involves the disintegration and subsequent scattering of a preexisting intracardiac thrombus. Hence, caution must be used when managing not only hemorrhagic complications but also ischemic complications after IV t-PA. Endovascular management may be the only effective treatment for this type of large vessel occlusion.

3.
World Neurosurg ; 141: 236-239, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32565380

RESUMO

BACKGROUND: Carotid free-floating thrombus (CFFT) is defined as a blood clot attached to the arterial wall with surrounding blood flow at its distal component. Although rare, it is a clinically significant cause of embolic stroke. CFFT within a stent has not been previously reported. CASE DESCRIPTION: We report a 64-year-old man who underwent carotid artery stenting for asymptomatic right carotid artery stenosis. Six months after carotid artery stenting, he was admitted to the emergency department 1 hour after onset of left hemiparesis and dysarthria. His National Institutes of Health Stroke Scale score was 10. His medical history was notable for hypertension, chronic renal insufficiency, and type 2 diabetes mellitus. Carotid ultrasonography showed a dumbbell-shaped CFFT attached to the carotid stent that was moving in synchrony with his heartbeat. CFFT removal was performed via an endovascular approach with manual suction using a Luer Lock syringe. The CFFT was completely removed without residual stenosis. Histologic examination suggested plaque rupture associated with a lipid-rich necrotic core. CONCLUSIONS: Carotid plaque formation and plaque rupture can occur within a carotid stent and present as a CFFT.


Assuntos
Artérias Carótidas/cirurgia , Estenose das Carótidas/cirurgia , Trombose/patologia , Artérias Carótidas/patologia , Artéria Carótida Interna/patologia , Artéria Carótida Interna/cirurgia , Estenose das Carótidas/complicações , Estenose das Carótidas/diagnóstico , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Sucção/efeitos adversos , Trombose/cirurgia
4.
Gan To Kagaku Ryoho ; 29(6): 949-53, 2002 Jun.
Artigo em Japonês | MEDLINE | ID: mdl-12090050

RESUMO

We administered an adjuvant chemotherapy of a bi-weekly low-dose CPT-11 + 5-FU on an outpatient basis to a patient with advanced sigmoid colon cancer and para-aortic lymph node metastasis. After 3 months, tumor markers fell to normal levels and the regression rate in the lymph node was over 80%. Throughout the period of treatment, there were no side effects, and there was no sign of recurrence for 6 months. In conclusion, we consider that with low-dose CPT-11 + 5-FU chemotherapy on an outpatient basis, the patient can maintain a high quality of life and show a massive effect, and that this regimen can be used as a first-line chemotherapy for advanced colon cancer.


Assuntos
Adenocarcinoma/tratamento farmacológico , Antineoplásicos Fitogênicos/administração & dosagem , Camptotecina/administração & dosagem , Neoplasias do Colo/tratamento farmacológico , Metástase Linfática , Adenocarcinoma/patologia , Idoso , Antineoplásicos/administração & dosagem , Camptotecina/análogos & derivados , Quimioterapia Adjuvante , Neoplasias do Colo/patologia , Feminino , Fluoruracila/administração & dosagem , Humanos , Irinotecano , Linfonodos/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...